Perspective Therapeutics (CATX) Non-Current Deferred Tax Liability (2023 - 2026)

Perspective Therapeutics has disclosed Non-Current Deferred Tax Liability across 4 years of filings, most recently posting $1.7 million for Q2 2026.

• In Q2 2026, Non-Current Deferred Tax Liability fell 31.78% year-over-year to $1.7 million; the TTM figure through Jun 2026 stood at $1.7 million (down 31.78% YoY), while the FY2025 annual figure was $1.7 million, down 31.78% from the prior year.
• Non-Current Deferred Tax Liability came in at $1.7 million for Q2 2026 at Perspective Therapeutics, roughly flat from $1.7 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $4.6 million in Q4 2023 to a low of $1.7 million in Q4 2025.
• Average Non-Current Deferred Tax Liability over 4 years is $3.0 million, with a median of $2.5 million recorded in 2024.
• Year-over-year, Non-Current Deferred Tax Liability tumbled 45.67% in 2024 and slumped 31.78% in 2025.
• Over 4 years, Non-Current Deferred Tax Liability stood at $4.6 million in 2023, then plunged by 45.67% to $2.5 million in 2024, then plunged by 31.78% to $1.7 million in 2025, then changed by 0.0% to $1.7 million in 2026.
• Per Business Quant data, the three most recent Non-Current Deferred Tax Liability figures were $1.7 million in Q2 2026, $1.7 million in Q1 2026, and $1.7 million in Q4 2025.